Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4 Suppl
pubmed:dateCreated
2003-8-7
pubmed:abstractText
Haemostatic system compounds not routinely studied, have been evaluated to define the individual risk of VTE (venous thromboembolism) and to influence the prognosis using selective drugs. Significantly high values of fibrinogen, free-TFPI, F1 + 2 fragments and TAT complexes on coagulation side and PAI-1 and TAFI on fibrinolysis side have been detected. Thrombin seems to have a role in the inhibition of TAFI dependent fibrinolysis not inhibited by heparin.
pubmed:language
ita
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Carboxypeptidase U, http://linkedlifedata.com/resource/pubmed/chemical/Escherichia coli Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Transport Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1, http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin, http://linkedlifedata.com/resource/pubmed/chemical/lipoprotein-associated coagulation..., http://linkedlifedata.com/resource/pubmed/chemical/prothrombin fragment 1.2, http://linkedlifedata.com/resource/pubmed/chemical/twin-arginine translocase complex...
pubmed:status
MEDLINE
pubmed:issn
0300-8916
pubmed:author
pubmed:issnType
Print
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
129-32
pubmed:dateRevised
2008-12-12
pubmed:meshHeading
pubmed-meshheading:12903570-Adult, pubmed-meshheading:12903570-Aged, pubmed-meshheading:12903570-Aged, 80 and over, pubmed-meshheading:12903570-Biological Markers, pubmed-meshheading:12903570-Carboxypeptidase U, pubmed-meshheading:12903570-Digestive System Neoplasms, pubmed-meshheading:12903570-Escherichia coli Proteins, pubmed-meshheading:12903570-Female, pubmed-meshheading:12903570-Fibrinogen, pubmed-meshheading:12903570-Fibrinolysis, pubmed-meshheading:12903570-Heparin, pubmed-meshheading:12903570-Humans, pubmed-meshheading:12903570-Lipoproteins, pubmed-meshheading:12903570-Male, pubmed-meshheading:12903570-Membrane Transport Proteins, pubmed-meshheading:12903570-Middle Aged, pubmed-meshheading:12903570-Peptide Fragments, pubmed-meshheading:12903570-Plasminogen Activator Inhibitor 1, pubmed-meshheading:12903570-Predictive Value of Tests, pubmed-meshheading:12903570-Prognosis, pubmed-meshheading:12903570-Prothrombin, pubmed-meshheading:12903570-Risk, pubmed-meshheading:12903570-Thrombophilia, pubmed-meshheading:12903570-Venous Thrombosis
pubmed:articleTitle
[New thrombophilia markers in digestive tract neoplasia].
pubmed:affiliation
Unità Operativa Complessa di Chirurgia Oncologica C, Istituto Nazionale Tumori Fondazione Pascale, Napoli.
pubmed:publicationType
Journal Article, English Abstract, Evaluation Studies